{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:23:32Z","timestamp":1760059412037,"version":"build-2065373602"},"reference-count":153,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Foundation for Polish Science (FNP) Scholarship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>This review looks at the causes of the association between thyroid dysfunction (hyperthyroidism and hypothyroidism) and ovarian cancer (OC) risk. Epidemiological data have revealed that thyroid dysfunction, particularly hyperthyroidism, is associated with increased risk, progression, and mortality in patients with OC. In addition, research studies and databases have demonstrated that both the expression and localization of thyroid hormone receptors alpha (TR\u03b1) and beta (TR\u03b2) and membrane thyroid hormone receptor integrin alpha V beta 3 (\u03b1v\u03b23) affect OC progression and survival in OC patients. Furthermore, this review described the levels of the thyroid hormones (THs) thyroxine (T4) and 3,5,3\u2032-triiodo-L-thyronine (T3) in the blood of OC patients and their role in OC progression. Moreover, we present studies that reported the relationship between hyperthyroidism and hypothyroidism and the levels of metabolic hormones in the blood and the possible effects on metabolic reprogramming in OC cells. We also report data indicating the relationship between the treatment of thyroid dysfunction and OC progression. Finally, the cited case studies described the essential case of struma ovarii, which is OC, including thyroid tissue. This review describes the link between thyroid dysfunction and OC risk and progression, which may be important in treating OC patients with thyroid dysfunction.<\/jats:p>","DOI":"10.3390\/biom15060870","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T14:03:11Z","timestamp":1750082591000},"page":"870","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship Between Thyroid Dysfunction and Ovarian Cancer"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7290-1009","authenticated-orcid":false,"given":"Justyna","family":"Gogola-Mruk","sequence":"first","affiliation":[{"name":"Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Gronostajowa 9, PL 30387 Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4187-2300","authenticated-orcid":false,"given":"Aleksandra","family":"Sirek","sequence":"additional","affiliation":[{"name":"Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Gronostajowa 9, PL 30387 Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Kumor","sequence":"additional","affiliation":[{"name":"Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Gronostajowa 9, PL 30387 Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Wojtaszek","sequence":"additional","affiliation":[{"name":"Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Gronostajowa 9, PL 30387 Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5112-0325","authenticated-orcid":false,"given":"Klaudia","family":"Roszak","sequence":"additional","affiliation":[{"name":"Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Gronostajowa 9, PL 30387 Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Kulig","sequence":"additional","affiliation":[{"name":"Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Gronostajowa 9, PL 30387 Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-1918","authenticated-orcid":false,"given":"Anna","family":"Ptak","sequence":"additional","affiliation":[{"name":"Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Gronostajowa 9, PL 30387 Cracow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-15-0989","article-title":"Hypothyroidism and hyperthyroidism and breast cancer risk: A nationwide cohort study","volume":"174","author":"Farkas","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-020-05675-6","article-title":"Association between thyroid gland diseases and breast cancer: A case\u2013control study","volume":"182","author":"Bach","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","article-title":"Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer","volume":"11","author":"Ness","year":"2000","journal-title":"Epidemiology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wang, T., Wang, X., Wu, J., and Li, X. (2024). Cusal relationship between thyroid dysfunction and ovarian cancer: A two-sample Mendelian randomization study. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12385-5"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/thy.2017.0063","article-title":"Hyperthyroidism, hypothyroidism, and cause-specific mortality in a large cohort of women","volume":"27","author":"Journy","year":"2017","journal-title":"Thyroid"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/onc.2015.262","article-title":"The thyroid hormone-\u03b1v\u03b23 integrin axis in ovarian cancer: Regulation of gene transcription and MAPK-dependent proliferation","volume":"35","author":"Cohen","year":"2016","journal-title":"Oncogene"},{"key":"ref_7","first-page":"298","article-title":"Effects of 3,5,3\u2019-triiodothyronine (T3) and follicle-stimulating hormone on apoptosis and proliferation of rat ovarian granulosa cells","volume":"56","author":"Zhang","year":"2013","journal-title":"Chin. J. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3892\/or.2016.4931","article-title":"Thyroid hormone receptor \u03b21 suppresses proliferation and migration by inhibiting PI3K\/Akt signalling in human colorectal cancer cells","volume":"36","author":"Zhu","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gogola-Mruk, J., Kumor, I., Wojtaszek, G., Kulig, K., and Ptak, A. (2024). GW0742 as a potential TR\u03b1 and TR\u03b2 antagonist reduces the viability and metabolic activity of an adult granulosa tumour cell line and simultaneously upregulates TR\u03b2 expression. Cancers, 16.","DOI":"10.3390\/cancers16234069"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","article-title":"Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer","volume":"45","year":"2023","journal-title":"GeroScience"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Huang, J., Chan, W.C., Ngai, C.H., Lok, V., Zhang, L., Lucero-Prisno, D.E., Xu, W., Zheng, Z.J., Elcarte, E., and Withers, M. (2022). Worldwide burden, risk factors, and temporal trends of ovarian cancer: A global study. Cancers, 14.","DOI":"10.3390\/cancers14092230"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: An overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_15","unstructured":"Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2024). Global Cancer Observatory: Cancer Today, International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.who.int\/today."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102074","DOI":"10.1016\/j.canep.2021.102074","article-title":"K; Million Women Study Collaborators. Ovarian cancer survival by stage, histotype, and prediagnostic lifestyle factors, in the prospective UK Million Women Study","volume":"76","author":"Gaitskell","year":"2022","journal-title":"Cancer Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mori, K.M., and Neubauer, N.L. (2013). Minimally invasive surgery in gynecologic oncology. Obs. Gynecol, 312982.","DOI":"10.1155\/2013\/312982"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cge.13566","article-title":"Epithelial ovarian cancer risk: A review of the current genetic landscape","volume":"97","author":"Flaum","year":"2020","journal-title":"Clin. Genet."},{"key":"ref_20","first-page":"e30561","article-title":"Aetiology, epidemiology, histopathology, classification, detailed evaluation, and treatment of ovarian cancer","volume":"14","author":"Zamwar","year":"2022","journal-title":"Cureus"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: Revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1586\/14737140.2013.811174","article-title":"Genetic changes in nonepithelial ovarian cancer","volume":"13","author":"Lambrechts","year":"2013","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2007.08.007","article-title":"Granulosa cell tumor of the ovary","volume":"34","author":"Pectasides","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"ref_24","unstructured":"Khan, Y.S., and Farhana, A. (2021). Histology, Thyroid Gland, StatPearls."},{"key":"ref_25","first-page":"306","article-title":"Peripheral metabolism of thyroid hormones: A review","volume":"5","author":"Kelly","year":"2000","journal-title":"Altern. Med. Rev."},{"key":"ref_26","first-page":"52","article-title":"Pituitary-thyroid interaction: Effects of thyroid hormone, non thyroidal illness and various agents on TSH secretion","volume":"15","author":"Vagenakis","year":"1988","journal-title":"Acta Med. Austriaca"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1074\/jbc.M511530200","article-title":"Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis","volume":"281","author":"Nikrodhanond","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_28","unstructured":"Mathew, P., Kaur, J., and Rawla, P. (2023). Hyperthyroidism, StatPearls."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"Lee","year":"2016","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1210\/jc.2013-2409","article-title":"The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis","volume":"99","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Savant, S.S., Sriramkumar, S., and O\u2019Hagan, H.M. (2018). The role of inflammation and inflammatory mediators in epithelial ovarian cancer. Cancers, 10.","DOI":"10.3390\/cancers10080251"},{"key":"ref_34","first-page":"907","article-title":"Thyroid hormones and female reproduction","volume":"99","author":"Silva","year":"2018","journal-title":"Biol. Reprod."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13193-020-01263-8","article-title":"Hypothyroidism presenting as ovarian cysts: A case series","volume":"12","author":"Tresa","year":"2021","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3329\/bjog.v33i1.43553","article-title":"Massive ovarian enlargement with multiple cysts mimicking ovarian neoplasm and primary hypothyroidism","volume":"33","author":"Perveen","year":"2020","journal-title":"Bangladesh J. Obs. Gynaecol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/jc.2006-1522","article-title":"Thyroid hormone signalling in human ovarian surface epithelial cells","volume":"92","author":"Rae","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1089\/thy.2024.0178","article-title":"Cancer risks of patients with Graves\u2019 disease who received antithyroid drugs as initial treatment: A nationwide population-based analysis","volume":"34","author":"Lee","year":"2024","journal-title":"Thyroid"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/bjc.2017.267","article-title":"History of thyroid disease and survival of ovarian cancer patients: Results from the Ovarian Cancer Association Consortium","volume":"117","author":"Minlikeeva","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5468\/ogs.24185","article-title":"Navigating the thyroid-gynecologic interplay: A systematic review and meta-analysis","volume":"67","author":"Ramadan","year":"2024","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"743721","DOI":"10.1155\/2013\/743721","article-title":"A large cohort study of hypothyroidism and hyperthyroidism in relation to gynecologic cancers","volume":"2013","author":"Kang","year":"2013","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Leung, J.H., Wang, S.Y., Leung, H.W.C., Yu, T.S., and Chan, A.L.F. (2024). Hypothyroidism and hyperthyroidism related to gynecologic cancers: A nationwide population-based cohort study. Sci. Rep., 14.","DOI":"10.1038\/s41598-023-50439-z"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/15321819.2021.2001003","article-title":"Hypothyroidism affects progression and outcomes of breast cancer but not ovarian cancer","volume":"43","author":"Elgebaly","year":"2022","journal-title":"J. Immunoass. Immunochem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2174\/0118715303266512231103075551","article-title":"Impact of PCOS on ovarian cancer and thyroid disorders: A review","volume":"24","author":"Mukherjee","year":"2024","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40738-016-0029-2","article-title":"PCOS and risk of endometrial, ovarian, and breast cancer: A systematic review","volume":"2","author":"Harris","year":"2016","journal-title":"Fertil. Res. Pract."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"PCOS and the risk of gynecological cancer: A systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0015-0282(97)81876-6","article-title":"Massive ovarian enlargement in primary hypothyroidism","volume":"67","author":"Hansen","year":"1997","journal-title":"Fertil. Steril."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.bbagen.2012.03.012","article-title":"Thyroid hormone receptors, cell growth and differentiation","volume":"1830","author":"Pascual","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/er.2009-0007","article-title":"Molecular aspects of thyroid hormone actions","volume":"31","author":"Cheng","year":"2010","journal-title":"Endocr. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrendo.2014.143","article-title":"Thyroid hormone receptors and resistance to thyroid hormone disorders","volume":"10","author":"Sidhaye","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of thyroid hormone action","volume":"122","author":"Brent","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1128\/MCB.20.22.8329-8342.2000","article-title":"Cloning and characterization of two novel thyroid hormone receptor beta isoforms","volume":"20","author":"Williams","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/108155890305100422","article-title":"Thyroid hormone action: Insight from transgenic mouse models","volume":"51","author":"Wondisford","year":"2003","journal-title":"J. Investig. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.mce.2015.10.016","article-title":"Nuclear import of the thyroid hormone receptor \u03b11 is mediated by importin 7, importin \u03b21, and adaptor importin \u03b11","volume":"419","author":"Roggero","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mce.2015.04.014","article-title":"Multiple exportins influence thyroid hormone receptor localization","volume":"411","author":"Subramanian","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1472-6483(10)60091-0","article-title":"Receptors for thyroid-stimulating hormone and thyroid hormones in human ovarian tissue","volume":"18","author":"Aghajanova","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00432-020-03241-7","article-title":"Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients","volume":"146","author":"Ditsch","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Heublein, S., Jeschke, U., Sattler, C., Kuhn, C., Hester, A., Czogalla, B., Trillsch, F., Mahner, S., Mayr, D., and Schmoeckel, E. (2022). Subcellular distribution of thyroid hormone receptor beta in ovarian cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052698"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/en.2005-0102","article-title":"Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis","volume":"146","author":"Bergh","year":"2005","journal-title":"Endocrinology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood-2014-07-587337","article-title":"Integrin \u03b1v\u03b23 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells","volume":"125","author":"Cayrol","year":"2015","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ddr.20265","article-title":"Integrin alpha(v)beta(3)-targeted cancer therapy","volume":"69","author":"Liu","year":"2008","journal-title":"Drug Dev. Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Yang, Y.S.H., Ko, P.J., Pan, Y.S., Lin, H.Y., Whang-Peng, J., Davis, P.J., and Wang, K. (2021). Role of thyroid hormone-integrin \u03b1v\u03b23-signal and therapeutic strategies in colorectal cancers. J. Biomed. Sci., 28.","DOI":"10.1186\/s12929-021-00719-5"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41389-020-00254-2","article-title":"The identification of nuclear \u03b1v\u03b23 integrin in ovarian cancer: Nonparadigmal localization with cancer promoting actions","volume":"9","author":"Weisz","year":"2020","journal-title":"Oncogenesis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0046-8177(97)90033-2","article-title":"Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas","volume":"28","author":"Liapis","year":"1997","journal-title":"Hum. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.3390\/ijms12063409","article-title":"Study on the expression and clinical significances of lewis y antigen and integrin \u03b1v, \u03b23 in epithelial ovarian tumors","volume":"12","author":"Wang","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"24237","DOI":"10.18632\/oncotarget.10757","article-title":"Crosstalk between integrin \u03b1v\u03b23 and ER\u03b1 contributes to thyroid hormone-induced proliferation of ovarian cancer cells","volume":"8","author":"Hsieh","year":"2017","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1878-0261.12845","article-title":"Constitutive activation of integrin \u03b1v\u03b23 contributes to anoikis resistance of ovarian cancer cells","volume":"15","author":"Dolinschek","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1515\/BC.2003.120","article-title":"Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3\/Vitronectin interaction","volume":"384","author":"Hapke","year":"2003","journal-title":"Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.biocel.2008.05.014","article-title":"Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells","volume":"40","author":"Benge","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-9966-32-36","article-title":"Expression of Lewis y antigen and integrin \u03b1v, \u03b23 in ovarian cancer and their relationship with chemotherapeutic drug resistance","volume":"32","author":"Gao","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.2353\/ajpath.2009.090028","article-title":"{beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favourable prognosis in patients with ovarian cancer","volume":"175","author":"Kaur","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_72","first-page":"1356","article-title":"Comparative study of alterations in tri-iodothyronine (T3) and thyroxine (T4) hormone levels in breast and ovarian cancer","volume":"30","author":"Rasool","year":"2014","journal-title":"Pak. J. Med. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21276\/aimdr.2018.4.4.BC8","article-title":"Study of prevalence of thyroid disorders in pregnant females of a tertiary care hospital of Garhwal region of Uttarakhand","volume":"4","author":"Pandey","year":"2018","journal-title":"Ann. Int. Med. Dent. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"205873921879670","DOI":"10.1177\/2058739218796706","article-title":"Detection of TSH, FT3, FT4, and TRAb in ovarian cancer with highly sensitive electrochemical immunoassay","volume":"16","author":"Yang","year":"2018","journal-title":"Eur. J. Inflamm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/mc.22735","article-title":"Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer","volume":"57","author":"Weingarten","year":"2018","journal-title":"Mol. Carcinog."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Shinderman-Maman, E., Cohen, K., Moskovich, D., Hercbergs, A., Werner, H., Davis, P.J., Ellis, M., and Ashur-Fabian, O. (2017). Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-16593-x"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s43032-024-01721-6","article-title":"Effects of thyroid hormones on cellular development in human ovarian granulosa tumor cells (KGN)","volume":"32","author":"Yu","year":"2024","journal-title":"Reprod. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jcp.21849","article-title":"Thyroid hormones induce cell proliferation and survival in ovarian granulosa cells COV434","volume":"221","author":"Mangialardo","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Miro, C., Nappi, A., Cicatiello, A.G., Di Cicco, E., Sagliocchi, S., Murolo, M., Belli, V., Troiani, T., Albanese, S., and Amiranda, S. (2021). Thyroid hormone enhances angiogenesis and the Warburg effect in squamous cell carcinomas. Cancers, 13.","DOI":"10.3390\/cancers13112743"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12672-017-0316-3","article-title":"The interplay between epithelial\u2013mesenchymal transition (EMT) and the thyroid hormones-\u03b1v\u03b23 axis in ovarian cancer","volume":"9","author":"Weingarten","year":"2018","journal-title":"Horm. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/ERC-17-0376","article-title":"Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells","volume":"25","author":"Chin","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3803\/EnM.2021.1198","article-title":"Deiodinases and the three types of thyroid hormone deiodination reactions","volume":"36","author":"Sabatino","year":"2021","journal-title":"Endocrinol. Metab."},{"key":"ref_83","first-page":"232","article-title":"The role of the iodothyronine deiodinases in the physiology and pathophysiology of thyroid hormone action","volume":"1","author":"Larsen","year":"2012","journal-title":"Eur. Thyroid. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.canlet.2020.11.011","article-title":"DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer","volume":"501","author":"Moskovich","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_85","first-page":"2298","article-title":"The selenoenzyme type I iodothyronine deiodinase: A new tumor suppressor in ovarian cancer","volume":"18","author":"Alfandari","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2019.06.010","article-title":"Genes associated with bowel metastases in ovarian cancer","volume":"154","author":"Mariani","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/endo-4-1-63","article-title":"Thyroid diabetes","volume":"4","author":"Rohdenburg","year":"1920","journal-title":"Endocrinology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2011.09.024","article-title":"Thyroid hormone differentially modulates Warburg phenotype in breast cancer cells","volume":"414","author":"Suhane","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3892\/ijo.2016.3668","article-title":"Triiodothyronine regulates cell growth and survival in renal cell cancer","volume":"49","author":"Czarnecka","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"C980","DOI":"10.1152\/ajpcell.00305.2008","article-title":"L-Thyroxine vs. 3,5,3\u2019-triiodo-L-thyronine and cell proliferation: Activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"296","author":"Lin","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ahmed, N., and Stenvers, K.L. (2013). Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research. Front. Oncol., 3.","DOI":"10.3389\/fonc.2013.00256"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.bcp.2008.07.023","article-title":"Anoikis: A necessary death program for anchorage-dependent cells","volume":"76","author":"Chiarugi","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Gandhi, N., and Das, G.M. (2019). Metabolic reprogramming in breast cancer and its therapeutic implications. Cells, 8.","DOI":"10.3390\/cells8020089"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1530\/REP-22-0443","article-title":"Visfatin increases the invasive potential of ovarian granulosa tumor spheroids by reprogramming glucose metabolism","volume":"165","author":"Marynowicz","year":"2023","journal-title":"Reproduction"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/CEJ.0000000000000064","article-title":"Visfatin derived from ascites promotes ovarian cancer cell migration through Rho\/ROCK signalling-mediated actin polymerization","volume":"24","author":"Li","year":"2015","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/IGC.0000000000000369","article-title":"Expression of adiponectin and its receptors is altered in epithelial ovarian tumors and ascites-derived ovarian cancer cell lines","volume":"25","author":"Tiwari","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.toxlet.2012.02.003","article-title":"Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK\/Stat, MAPK\/ERK and PI3K\/Akt signalling pathways in human ovarian cancer cell","volume":"210","author":"Ptak","year":"2012","journal-title":"Toxicol. Lett."},{"key":"ref_99","first-page":"646271","article-title":"Adipocytokines in thyroid dysfunction","volume":"2013","author":"Aydogan","year":"2013","journal-title":"Inflamm"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Wang, X., Sun, J., Li, J., Cai, L., Chen, Q., Wang, Y., Yang, Z., Liu, W., Lv, H., and Wang, Z. (2023). Bidirectional Mendelian randomization study of insulin-related traits and risk of ovarian cancer. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1131767"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1210\/en.2001-211408","article-title":"Functional insulin receptors on human epithelial ovarian carcinoma cells: Implications for IGF-II mitogenic signalling","volume":"143","author":"Kalli","year":"2002","journal-title":"Endocrinology"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Joung, K.H., Jeong, J.W., and Ku, B.J. (2015). The association between type 2 diabetes mellitus and women cancer: The epidemiological evidence and putative mechanisms. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/920618"},{"key":"ref_103","first-page":"79","article-title":"Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism","volume":"76","author":"Blackman","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Verga Falzacappa, C., Mangialardo, C., Madaro, L., Ranieri, D., Lupoi, L., Stigliano, A., Torrisi, M.R., Bouch\u00e8, M., Toscano, V., and Misiti, S. (2011). Thyroid hormone T3 counteracts STZ induced diabetes in mouse. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019839"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Yang, W., Jin, C., Wang, H., Lai, Y., Li, J., and Shan, Z. (2023). Subclinical hypothyroidism increases insulin resistance in normoglycemic people. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1106968"},{"key":"ref_106","first-page":"E593","article-title":"Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans","volume":"248","author":"Dimitriadis","year":"1985","journal-title":"Am. J. Physiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"152850","DOI":"10.4061\/2011\/152850","article-title":"Why can insulin resistance be a natural consequence of thyroid dysfunction?","volume":"2011","author":"Brenta","year":"2011","journal-title":"J. Thyroid. Res."},{"key":"ref_108","first-page":"95","article-title":"Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper and hypothyroid subjects before and after treatment","volume":"2","author":"Lundquist","year":"1985","journal-title":"Diabetes Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e210063","DOI":"10.1530\/ETJ-21-0063","article-title":"Association of thyroid function with insulin resistance: Data from two population-based studies","volume":"11","author":"Spira","year":"2022","journal-title":"Eur. Thyroid. J."},{"key":"ref_110","first-page":"120","article-title":"Diabetes and thyroid diseases-a review","volume":"23","author":"Sathish","year":"2003","journal-title":"Int. J. Diabetes Dev. Ctries."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2013.02.006","article-title":"Obesity-associated adipokines correlate with survival in epithelial ovarian cancer","volume":"129","author":"Diaz","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcb.20188","article-title":"Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction","volume":"93","author":"Yaturu","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10520295.2019.1627419","article-title":"Tumor apelin immunoreactivity is correlated with body mass index in ovarian high grade serous carcinoma","volume":"95","author":"Unal","year":"2020","journal-title":"Biotech. Histochem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/1541-7786.MCR-18-0989","article-title":"Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis","volume":"17","author":"Neelakantan","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.toxlet.2017.01.006","article-title":"Bisphenol A and its derivatives tetrabromobisphenol A and tetrachlorobisphenol A induce apelin expression and secretion in ovarian cancer cells through a peroxisome proliferator-activated receptor gamma-dependent mechanism","volume":"269","author":"Hoffmann","year":"2017","journal-title":"Toxicol. Lett."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.18632\/oncotarget.2032","article-title":"Apelin promotes lymphangiogenesis and lymph node metastasis","volume":"5","author":"Berta","year":"2014","journal-title":"Oncotarget"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/1541-7786.MCR-20-0991","article-title":"Adipokine Apelin\/APJ Pathway Promotes Peritoneal Dissemination of Ovarian Cancer Cells by Regulating Lipid Metabolism","volume":"19","author":"Dogra","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/bab.2142","article-title":"Supplement therapy with apelin for improving the TSH level and lipid disorders in PTU-induced hypothyroid rats","volume":"69","author":"Badavi","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1006\/bbrc.2002.6575","article-title":"The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats","volume":"291","author":"Taheri","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_120","first-page":"16394","article-title":"Serum apelin levels in patients with thyroid dysfunction","volume":"8","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ando.2013.12.001","article-title":"Assessment of serum apelin and lipocalin-2 levels in patients with subclinical hypothyroidism","volume":"75","author":"Zorlu","year":"2014","journal-title":"Ann. Endocrinol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20030382","article-title":"Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids","volume":"198","author":"Wittamer","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1631\/jzus.B2100392","article-title":"Chemerin promotes proliferation and migration of ovarian cancer cells by upregulating expression of PD-L1","volume":"23","author":"Gao","year":"2022","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Schmitt, M., Gallistl, J., Sch\u00fcler-Toprak, S., Fritsch, J., Buechler, C., Ortmann, O., and Treeck, O. (2022). Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response. Cancers, 14.","DOI":"10.3390\/cancers14174108"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Treeck, O., Buechler, C., and Ortmann, O. (2019). Chemerin and Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153750"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.toxlet.2018.04.004","article-title":"Bisphenol A and its derivatives decrease expression of chemerin, which reverses its stimulatory action in ovarian cancer cells","volume":"291","author":"Hoffmann","year":"2018","journal-title":"Toxicol. Lett."},{"key":"ref_127","first-page":"44","article-title":"The potential influence of hyperthyroidism on circulating adipokines chemerin, visfatin, and omentin","volume":"13","author":"Alshaikh","year":"2019","journal-title":"Int. J. Health Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.7150\/jca.62496","article-title":"Resistin Expression in Epithelial Ovarian Cancer promotes the Proliferation and Migration of Ovarian Cancer Cells to Worsen Prognosis","volume":"12","author":"Pang","year":"2021","journal-title":"J. Cancer"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Zhou, L., Song, K., and Luo, W. (2023). Association between circulating resistin levels and thyroid dysfunction: A systematic review and meta-analysis. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1071922"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2265.2003.01897.x","article-title":"Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function","volume":"59","author":"Iglesias","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"ref_131","first-page":"306750","article-title":"Serum resistin and insulin-like growth factor-1 levels in patients with hypothyroidism and hyperthyroidism","volume":"2013","author":"Temizel","year":"2013","journal-title":"J. Thyroid. Res."},{"key":"ref_132","first-page":"131","article-title":"Circulating resistin levels are lower in hypothyroid women but independent from thyroid hormones concentrations","volume":"29","author":"Owecki","year":"2008","journal-title":"Neuroendocr. Lett."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"78680","DOI":"10.18632\/oncotarget.12019","article-title":"Downregulated resistin level in consequence of decreased neutrophil counts in untreated Grave\u2019s disease","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_134","first-page":"522","article-title":"Over-expression of nicotinamide phosphoribosyltransferase in ovarian cancers","volume":"3","author":"Shackelford","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.4161\/15384101.2015.942208","article-title":"BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer","volume":"13","author":"Li","year":"2014","journal-title":"Cell Cycle"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF03346482","article-title":"Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function","volume":"32","author":"Ozkaya","year":"2009","journal-title":"J. Endocrinol. Investig."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1113\/jphysiol.2009.172510","article-title":"Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue","volume":"587","author":"Caminos","year":"2009","journal-title":"J. Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11695-009-9882-y","article-title":"Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss","volume":"20","author":"Handisurya","year":"2010","journal-title":"Obes. Surg."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1530\/EJE-11-0180","article-title":"Serum vaspin levels in hypothyroid patients","volume":"165","author":"Cinar","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1038\/s41467-020-17383-2","article-title":"ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment","volume":"11","author":"Yeung","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12020-014-0460-2","article-title":"Evaluation of body composition changes, epicardial adipose tissue, and serum omentin-1 levels in overt hypothyroidism","volume":"49","author":"Cerit","year":"2015","journal-title":"Endocrine"},{"key":"ref_142","unstructured":"Patil, N., Rehman, A., Anastasopoulou, C., Jialal, I., and Saathoff, A.D. (2024). Hypothyroidism (Nursing), StatPearls."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/thy.2010.1644","article-title":"Genetic susceptibility to autoimmune thyroid disease: Past, present, and future","volume":"20","author":"Tomer","year":"2010","journal-title":"Thyroid"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0256-4947.77500","article-title":"Effect of thyroid hormone replacement therapy on ovarian volume and androgen hormones in patients with untreated primary hypothyroidism","volume":"31","author":"Muderris","year":"2011","journal-title":"Ann. Saudi. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000475807","article-title":"Case of Ovarian Cancer in a Woman with Undiagnosed Graves\u2019 Disease: A Case Report and Review of the Literature","volume":"10","author":"Markman","year":"2017","journal-title":"Case Rep. Oncol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2006.02.018","article-title":"Ovarian carcinoma with thyroid metastases causing clinical hypothyroidism: A case report","volume":"102","author":"Skarf","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1507\/endocrj.K06-139","article-title":"Severe ascites with hypothyroidism and elevated CA125 concentration: A case report","volume":"54","author":"Kimura","year":"2007","journal-title":"Endocr. J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12022-015-9394-3","article-title":"Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii","volume":"26","author":"Tan","year":"2015","journal-title":"Endocr. Pathol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00003072-200010000-00001","article-title":"Struma ovarii with hyperthyroidism","volume":"25","author":"Grandet","year":"2000","journal-title":"Clin. Nucl. Med."},{"key":"ref_150","first-page":"24-0082","article-title":"Hyperthyroidism in thyroid carcinoma originating in struma ovarii","volume":"2024","author":"Mesquita","year":"2024","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bulcan.2017.11.014","article-title":"Cancer thyro\u00efdien sur struma ovarii: G\u00e9n\u00e9ralit\u00e9s et principes de prise en charge [Thyroid carcinoma on struma ovarii: Diagnosis and treatment]","volume":"105","author":"Lebreton","year":"2018","journal-title":"Bull. Cancer"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Koehler, V.F., Keller, P., Waldmann, E., Schwenk, N., Kitzberger, C., Schmohl, K.A., Kn\u00f6sel, T., Stief, C.G., and Spitzweg, C. (2021). An unusual case of struma ovarii. Endocrinol. Diabetes Metab. Case Rep., 20-0142.","DOI":"10.1530\/EDM-20-0142"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1590\/S0041-87812002000300006","article-title":"Hypothyroidism following struma ovarii tumor resection: A case report","volume":"57","author":"Carvalho","year":"2002","journal-title":"Rev. Hosp. Clin."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/6\/870\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:52:05Z","timestamp":1760032325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/6\/870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":153,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["biom15060870"],"URL":"https:\/\/doi.org\/10.3390\/biom15060870","relation":{},"ISSN":["2218-273X"],"issn-type":[{"type":"electronic","value":"2218-273X"}],"subject":[],"published":{"date-parts":[[2025,6,14]]}}}